TCL-137: Duvelisib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results From the Phase 2 PRIMO Trial

作者：Lauren Pinter‐Brown, Neha Mehta–Shah, Pier Luigi Zinzani, Eric D. Jacobsen, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppe Gritti, Koji Izutsu, Ohad S. Bentur, David Sidransky, Michael Andria, Jonathan E. Brammer, Barbara Pro, Christopher P. Fox, Steven M. Horwitz · 发表于：Clinical Lymphoma Myeloma & Leukemia · 年份：2025 · DOI：10.1016/s2152-2650(25)02489-9 · 被引用次数：1 · 研究领域：Lymphoma Diagnosis and Treatment、CAR-T cell therapy research、T-cell and Retrovirus Studies